Two Year Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) presented by Michael Haude, MD, PhD at CRT 2015
Session Name: The iMPACT Trials: Session I
Track: Coronary